Fund I first close · Business services

Vitamin°C announces €18 million first close

The debut fund invests in early-stage climate mitigation and adaptation technologies.

Vitamin°C announced an €18 million first close for its debut venture fund on March 24, 2026. The team operates from Zurich and San Francisco and focuses on pre-seed and seed investments.

The fund is backed by European entrepreneurial families. Its investment strategy spans energy, food and agriculture, carbon removal and climate adaptation, with initial investments generally ranging from €500,000 to €1.5 million.

Founding partners Nathalie Moral and Sophie Lamparter combine impact-investing and company-building experience with support for international expansion. The team aims to connect European founders with US customers, hires and investors, while helping companies develop evidence of their climate impact and commercial potential.

Use of funds

Back pre-seed and seed climate mitigation and adaptation companies

Funding history

Fund I first close · This round€18M

Sources

  1. Vitamin C original first-close announcementlinkedin.com · Mar 24, 2026
  2. Vitamin C fund and manager identityvitaminc.vc · May 16, 2026
  3. Vitamin C debut fund first closeeu-startups.com · Mar 24, 2026